GUGGENHIME ANDREW 4
4 · Vaxcyte, Inc. · Filed Apr 9, 2025
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
GUGGENHIME ANDREW
PRESIDENT AND CFO
Transactions
- Exercise/Conversion
Common Stock
2025-04-07$20.93/sh+4,777$99,983→ 131,950 total - Exercise/Conversion
Stock Option (right to buy)
2025-04-07−4,777→ 121,115 totalExercise: $20.93Exp: 2031-03-31→ Common Stock (4,777 underlying)
Footnotes (1)
- [F1]Stock Option is fully vested and exercisable.